Rebecca Auer

4.0k total citations
36 papers, 647 citations indexed

About

Rebecca Auer is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Rebecca Auer has authored 36 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 27 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Rebecca Auer's work include Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (27 papers) and Viral-associated cancers and disorders (6 papers). Rebecca Auer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (27 papers) and Viral-associated cancers and disorders (6 papers). Rebecca Auer collaborates with scholars based in United Kingdom, United States and Spain. Rebecca Auer's co-authors include Finbarr E. Cotter, John G. Gribben, Martin Dreyling, Simon Rule, Janet Matthews, Chris Fegan, Maria Calaminici, Brad S. Kahl, Csaba Bödör and André Goy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Rebecca Auer

34 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Auer United Kingdom 14 469 445 248 143 100 36 647
Carsten Schwänen Germany 6 325 0.7× 329 0.7× 187 0.8× 103 0.7× 106 1.1× 8 497
Marco Fangazio Italy 10 483 1.0× 346 0.8× 273 1.1× 219 1.5× 220 2.2× 20 727
Dominique Penther France 12 239 0.5× 258 0.6× 117 0.5× 104 0.7× 108 1.1× 32 440
Maria Delioukina United States 13 426 0.9× 168 0.4× 308 1.2× 157 1.1× 168 1.7× 33 652
Takashi Akasaka Japan 15 323 0.7× 229 0.5× 194 0.8× 222 1.6× 120 1.2× 45 660
Junji Hiraga Japan 8 266 0.6× 142 0.3× 185 0.7× 119 0.8× 102 1.0× 17 464
Sietse Aukema Germany 9 568 1.2× 324 0.7× 392 1.6× 92 0.6× 56 0.6× 15 648
Vaishalee P. Kenkre United States 13 258 0.6× 208 0.5× 260 1.0× 73 0.5× 120 1.2× 37 456
Eva Maria Murga Penas Germany 14 239 0.5× 196 0.4× 247 1.0× 182 1.3× 111 1.1× 31 550
Silvia Zibellini Italy 13 459 1.0× 629 1.4× 129 0.5× 154 1.1× 242 2.4× 29 761

Countries citing papers authored by Rebecca Auer

Since Specialization
Citations

This map shows the geographic impact of Rebecca Auer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Auer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Auer more than expected).

Fields of papers citing papers by Rebecca Auer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Auer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Auer. The network helps show where Rebecca Auer may publish in the future.

Co-authorship network of co-authors of Rebecca Auer

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Auer. A scholar is included among the top collaborators of Rebecca Auer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Auer. Rebecca Auer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durot, Éric, Jithma P. Abeykoon, Damien Roos‐Weil, et al.. (2025). Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia. Seminars in Hematology. 62(2). 120–125. 1 indexed citations
2.
Tedeschi, Alessandra, Rebecca Auer, Francesco Autore, et al.. (2025). Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma. Seminars in Hematology. 62(2). 106–112.
3.
Kothari, Jaimal, Toby A. Eyre, Ali Rismani, et al.. (2024). PembroWM : A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia. British Journal of Haematology. 205(6). 2273–2281. 3 indexed citations
4.
Tute, Ruth de, Nicholas Counsell, Laura Clifton‐Hadley, et al.. (2024). Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. Leukemia. 38(4). 822–828.
5.
Hokland, Peter, Mansi Shah, Kevin A. David, et al.. (2020). How I treat advanced Hodgkin lymphoma — a global view. British Journal of Haematology. 190(6). 837–850. 2 indexed citations
6.
Rule, Simon, Martin Dreyling, André Goy, et al.. (2019). Long-Term Outcomes with Ibrutinib Versus the Prior Regimen: A Pooled Analysis in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) with up to 7.5 Years of Extended Follow-up. Blood. 134(Supplement_1). 1538–1538. 16 indexed citations
7.
Tappenden, Paul, Christopher Carroll, John Stevens, et al.. (2018). Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(1). 7–18. 2 indexed citations
8.
Rule, Simon, Martin Dreyling, André Goy, et al.. (2017). Median 3.5-Year Follow-up of Ibrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis. Blood. 130. 151–151. 4 indexed citations
9.
Rule, Simon, Martin Dreyling, Gregory P. Hess, et al.. (2016). Overall survival outcomes in patients with mantle-cell lymphoma (MCL) treated with Ibrutinib in a pooled analysis of 370 patients from 3 international open-label studies. Haematologica. 2 indexed citations
10.
Owen, Roger G., Guy Pratt, Rebecca Auer, et al.. (2014). Guidelines on the diagnosis and management of Waldenström macroglobulinaemia. British Journal of Haematology. 165(3). 316–333. 35 indexed citations
11.
Cheah, Chan Y., Anupkumar George, Eva Giné, et al.. (2013). Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Annals of Oncology. 24(8). 2119–2123. 83 indexed citations
12.
13.
Auer, Rebecca. (2011). The coming of age of microRNA for B cell lymphomas. Histopathology. 58(1). 39–48. 7 indexed citations
14.
Cotter, Finbarr E. & Rebecca Auer. (2007). Genetic alteration associated with chronic lymphocytic leukemia. Cytogenetic and Genome Research. 118(2-4). 310–319. 12 indexed citations
15.
Auer, Rebecca, John G. Gribben, & Finbarr E. Cotter. (2007). Emerging therapy for chronic lymphocytic leukaemia. British Journal of Haematology. 139(5). 635–644. 12 indexed citations
16.
Auer, Rebecca, et al.. (2007). The 13q and 11q B‐cell chronic lymphocytic leukaemia‐associated regions derive from a common ancestral region in the zebrafish. British Journal of Haematology. 137(5). 443–453. 20 indexed citations
17.
Humphries, Adam & Rebecca Auer. (2006). Relapsed plasma cell leukaemia manifesting as a protein‐losing enteropathy. British Journal of Haematology. 134(4). 355–355. 1 indexed citations
18.
Auer, Rebecca, Guillaume Dighiero, Lynn R. Goldin, et al.. (2006). Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia. British Journal of Haematology. 136(1). 73–79. 13 indexed citations
19.
Auer, Rebecca, Jane Starczynski, Suzanne McElwaine, et al.. (2005). Identification of a potential role forPOU2AF1 andBTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes Chromosomes and Cancer. 43(1). 1–10. 32 indexed citations
20.
Bertoni, Francesco, Annarita Conconi, Sergio Cogliatti, et al.. (2004). Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22‐23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research. British Journal of Haematology. 124(3). 289–298. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carsten Schwänen Breakdown of academic impact, for papers by Marco Fangazio Breakdown of academic impact, for papers by Dominique Penther Breakdown of academic impact, for papers by Maria Delioukina Breakdown of academic impact, for papers by Takashi Akasaka Breakdown of academic impact, for papers by Junji Hiraga Breakdown of academic impact, for papers by Sietse Aukema Breakdown of academic impact, for papers by Vaishalee P. Kenkre Breakdown of academic impact, for papers by Eva Maria Murga Penas Breakdown of academic impact, for papers by Silvia Zibellini
Rankless by CCL
2026